Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged - Al Jazeera English

Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged - Al Jazeera English
The move disappointed investors who were hoping products would continue to drive growth.
Pfizer Inc. kept its outlook for annual sales of its Covid-19 vaccine and treatment, disappointing investors who looked for the products to continue driving growth. Through mid-April, Pfizer said it… [+4330 chars] Read More

Related Stories

See All